After deliberating for fewer than six hours, a New Jersey jury returned a 7-to-1 verdict in favor of Novartis Pharmaceuticals Corporation in a thirteen-day trial involving Zometa, a bisphosphonate drug given to cancer patients suffering metastases…
The U.S. Court of Appeals for the Second Circuit affirmed summary judgment in favor of Firm client General Electric International, Inc. (“GEII”), bringing to a close a wrongful death and survival action brought against the company…
Judge P.K. Holmes of the U.S. District Court for the Western District of Arkansas granted Firm client Novartis Pharmaceuticals Corporation’s motion to dismiss in McDaniel v. Novartis Pharm. Corp., No. 2:08-cv-02088-PKH (W.D. Ark. Jan. 6, 2012)…
The Second Circuit affirmed a defense verdict in Hogan v. Novartis Pharm. Corp., 1:06-260-BMC (E.D.N.Y.). On appeal, plaintiff/appellant argued that the district court erred in denying her last-minute request to present testimony from a treating oral…
Hogan v. Novartis Pharm. Corp., 1:06-cv-00260-BMC-RER (E.D.N.Y. May 3, 2011)
After a two-week long trial, a jury in the Eastern District of California returned a verdict in favor of Novartis Pharmaceuticals Corporation in Hill v. Novartis Pharm. Corp., No. 1:06-cv-00939-JSR-SAB (E.D. Cal. June 26, 2013). Judge…
